Ulthera CEO - Matthew Likens - to Present at Two Upcoming Healthcare Conferences
MESA, Ariz., Nov. 22, 2011 /PRNewswire/ -- Matthew Likens, president and CEO of Ulthera [1], Inc. – a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – is scheduled to present at two upcoming healthcare conferences:-- Tuesday, Nov. 29 at 2:10 p.m. EST23rd Annual Piper Jaffray Healthcare Conference [2] in New York City, Nov. 29-30, 2011Location: The New York Palace Hotel, 455 Madison Avenue, New York 10022 -- Tuesday, Dec. 6 at 12:00 p.m. PT6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference [3] in San Francisco, Dec. 6, 2011Location: St. Regis, 125 3rd Street, San Francisco 94103Likens will present an overview of the company as well as its accomplishments to date and prospects for the future.
(Logo: http://photos.prnewswire.com/prnh/20111122/NY10856LOGO [4] )
About Ulthera
Ulthera®, Inc. is a global, commercial-stage medical device
company pioneering aesthetic and medical applications using its
therapeutic ultrasound platform technology. The Ulthera® System
is the first and only energy-based device to receive FDA clearance
for a non-invasive aesthetic lift indication. The first application
for Ultherapy® – the procedure enabled by the System
– is a non-invasive face and neck treatment to achieve a brow
lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a
privately held company backed by top tier venture capital firms, New
Enterprise Associates [5] and Ap
'/>"/>
SOURCE [7]